Prostate-specificy-antigen testing for early diagnosis of prostate cancer.

被引：307

作者：

Barry, MJ

机构：

[1] Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2001年 / 344卷 / 18期

关键词：

D O I：

10.1056/NEJM200105033441806

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1373 / 1377

页数：5

共 38 条

[1]

*AM UR ASS, 2000, ONCOLOGY, V14, P277

[2]

*AM UR ASS, 2000, ONCOLOGY HUNTINGT, V14, P280

[3]

[Anonymous], NIH PUBLICATION

[4]

[Anonymous], 2000, Oncology

[5] The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng./ml.: Relation to biopsy strategy [J].

Babaian, RJ ;

Johnston, DA ;

Naccarato, W ;

Ayala, A ;

Bhadkamkar, VA ;

Fritsch, HA .

JOURNAL OF UROLOGY, 2001, 165 (03) :757-760

[6] Extended field prostate biopsy enhances cancer detection [J].

Babaian, RJ .

UROLOGY, 2000, 55 (04) :453-456

[7]

Boer R, 1999, PROSTATE, V40, P130

[8] A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: The only rational approach for men 50 years old and older [J].

Carter, HB .

UROLOGY, 2000, 55 (06) :796-799

[9] Prostate-specific antigen testing for early diagnosis of prostate cancer: Formulation of guidelines [J].

Carter, HB ;

Pearson, JD .

UROLOGY, 1999, 54 (05) :780-786

[10] Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease - A prospective multicenter clinical trial [J].

Catalona, WJ ;

Partin, AW ;

Slawin, KM ;

Brawer, MK ;

Flanigan, RC ;

Patel, A ;

Richie, JP ;

deKernion, JB ;

Walsh, PC ;

Scardino, PT ;

Lange, PH ;

Subong, ENP ;

Parson, RE ;

Gasior, GH ;

Loveland, KG ;

Southwick, PC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19) :1542-1547

← 1 2 3 4 →